IP Library › Assignment 064132/0202
Patent Assignment
Reel/Frame 064132/0202

Nunc Pro Tunc Assignment

Recorded: 2023-06-30 Pages: 8
Assignors
DEUTSCHES KREBSFORSCHUNGSZENTRUM
Executed: 2023-06-15
Assignee
NOVARTIS PHARMA AG
FORUM 1, NOVARTIS CAMPUS, BASEL, 4056, SWITZERLAND
Covered Properties (4)
Use of Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), as Agents for the Treatment of Prostate Cancer
Application: 17/143,280 →
Publication: US 2021/0283279
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma) as Agents for the Treatment of Prostate Cancer
Application: 17/110,558 →
Publication: US 2021/0177996
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma), Their Use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
Application: 16/038,729 →
Publication: US 2019/0008988
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma) as Agents for the Treatment of Prostate Cancer
Application: 16/551,198 →
Publication: US 2019/0374660
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 29, 2018
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 046737/0135 →
Assignment of Assignor's Interest Aug 29, 2018
From: KLIEM, HANS-CHRISTIAN
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046969/0540 →
Assignment of Assignor's Interest Aug 29, 2018
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 046732/0661 →
Assignment of Assignor's Interest Oct 12, 2018
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 047146/0548 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Dec 20, 2018
From: UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.
Reel/Frame 047972/0664 →
Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No 16/038,729 at Reel 047972/Frame 0664 Nov 12, 2019
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 050993/0581 →
Declaration to Correct Assignment Record Following Declaration Recorded on November 12, 2019 in Application No. 16/038,729 Feb 21, 2020
From: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.; UNIVERSITY OF HEIDELBERG
Reel/Frame 051989/0869 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Feb 21, 2020
From: UNIVERSITY OF HEIDELBERG
To: MOLECULAR INSIGHT PHARMACEUTICAL, INC.
Reel/Frame 051989/0187 →
Assignment of Assignor's Interest Mar 13, 2020
From: KRATOCHWIL, CLEMENS
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 052107/0330 →
Assignment of Assignor's Interest Mar 13, 2020
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 052107/0134 →
Assignment of Assignor's Interest Mar 13, 2020
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 052107/0396 →
Assignment of Assignor's Interest Dec 3, 2020
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 054530/0239 →
Assignment of Assignor's Interest Dec 3, 2020
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 054530/0342 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Feb 9, 2021
From: UNIVERSITY OF HEIDELBERG
To: UNIVERSITY OF HEIDELBERG; MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 055266/0204 →
Assignment of Assignor's Interest Jun 6, 2021
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 056448/0833 →
Assignment of Assignor's Interest Jun 6, 2021
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 056448/0827 →
Corrective Assignment to Correct the 16/551/198 Corrected Assignment Record After Attempt by a Thrid Party Also Second Receiving Party Added Previously Recorded at Reel: 051989 Frame: 0187. Assignor(S) Hereby Confirms the Assingment. Nov 20, 2021
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058567/0798 →
Second Declaration to Correct Assignment Record After Attempt by a Third Party to Record an Improper Assignment in Application No. 16/038,729 at Reel 051989/Frame 0869 Feb 9, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059098/0285 →
Declaration of Brenda Herschbach Jarrell Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0227 →
Declaration of Brenda Herschbach Jarrell Apr 12, 2022
From: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 059690/0237 →
Assignment of Assignor's Interest Jun 30, 2023
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 064132/0352 →